Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 952Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 19Blake Cassels & Graydon LLP

02 7Janssen Inc.

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Darunavir

Brand Name : PREZISTA

Patent Number : 2469343

Filing Date : 2002-12-12

Strength per Unit : 300mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2022-12-12

Date Granted : 2008-05-13

blank

02

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Darunavir

Brand Name : PREZISTA

Patent Number : 2224738

Filing Date : 1996-06-28

Strength per Unit : 300mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2016-06-28

Date Granted : 2002-08-27

blank

03

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Darunavir

Brand Name : PREZISTA

Patent Number : 2140929

Filing Date : 1993-08-24

Strength per Unit : 300mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2013-08-24

Date Granted : 2006-09-12

blank

04

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Darunavir

Brand Name : PREZISTA

Patent Number : 2485834

Filing Date : 2003-05-15

Strength per Unit : 300mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2023-05-16

Date Granted : 2007-07-14

blank

05

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Darunavir

Brand Name : PREZISTA

Patent Number : 2485834

Filing Date : 2003-05-16

Strength per Unit : 400 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2023-05-16

Date Granted : 2007-07-17

blank

06

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Darunavir

Brand Name : PREZISTA

Patent Number : 2469343

Filing Date : 2002-12-12

Strength per Unit : 400 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2022-12-12

Date Granted : 2008-05-13

blank

07

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Darunavir

Brand Name : PREZISTA

Patent Number : 2485834

Filing Date : 2003-05-16

Strength per Unit : 600 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2023-05-16

Date Granted : 2007-07-17

blank

08

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Darunavir

Brand Name : PREZISTA

Patent Number : 2469343

Filing Date : 2002-12-12

Strength per Unit : 600 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2022-12-12

Date Granted : 2008-05-13

blank

09

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Darunavir

Brand Name : PREZISTA

Patent Number : 2469343

Filing Date : 2002-12-12

Strength per Unit : 75 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2022-12-12

Date Granted : 2008-05-13

blank

10

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Darunavir

Brand Name : PREZISTA

Patent Number : 2485834

Filing Date : 2003-05-16

Strength per Unit : 75 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2023-05-16

Date Granted : 2007-07-17

blank